Vivet Therapeutics
Vivet Therapeutics is a gene Therapy for Orphan Diseases founded in 2016 by Jean-Philippe Combal.
4
Funding Rounds
$767.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Je*********** Co**** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Vivet Therapeutics has raised a total of $90.2m in funding over 4 rounds.
Key Insights:
- Vivet Therapeutics , March 2019: $50.9m
- Vivet Therapeutics Series A round, May 2017: $39.3m
- Vivet Therapeutics Corporate funding round, March 2019: $635.8m
- Vivet Therapeutics funding round, May 2017: $41m
Vivet Therapeutics , March 2019
$50.9m
Vivet Therapeutics Series A round, May 2017
$39.3m
Vivet Therapeutics funding round, May 2017
$41m
Vivet Therapeutics Corporate funding round, March 2019
$635.8m
Industries
Vivet Therapeutics is active in the following industries: